U.S. Cases Rise 1.9%; California Deaths Up Again: Virus Update

us-cases-rise-1.9%;-california-deaths-up-again:-virus-update

(Bloomberg) — U.S. cases rose 1.9%, matching the average daily rise over the past week. Texas hospitalizations topped 10,000 for the first time and California suffered its second-highest day of deaths, while Florida’s biggest county had a record number of patients in its intensive-care units.Elsewhere in the U.S., New Jersey’s transmission rate dropped to 0.98 … Read more U.S. Cases Rise 1.9%; California Deaths Up Again: Virus Update

Biogen: Approval Prospects for Aducanumab Amount to a Flip of a Coin, Says J.P. Morgan

biogen:-approval-prospects-for-aducanumab-amount-to-a-flip-of-a-coin,-says-jp.-morgan

Not all biotechs are highflyers in 2020. Despite some pharma companies’ elevated coronavirus driven valuations, some have had to settle for more pedestrian performances.Take for instance biotech Biogen (BIIB). The large cap has had a middling 2020 so far, with shares down by 6% since the turn of the year.Might that be about to change … Read more Biogen: Approval Prospects for Aducanumab Amount to a Flip of a Coin, Says J.P. Morgan

Is United Airlines Stock a Buy Right Now? This Is What You Need To Know

is-united-airlines-stock-a-buy-right-now?-this-is-what-you-need-to-know

The airline industry has been hit hard by COVID-19. Border closures and shelter in place measures brought the industry to a standstill during the virus’ initial wave, as air traffic was grounded across the globe.Whether the pandemic has peaked or not, United Airlines (UAL) upcoming flight schedule acknowledges normality is still a way off. Air … Read more Is United Airlines Stock a Buy Right Now? This Is What You Need To Know

Did Hedge Funds Make The Right Call On Sarepta Therapeutics Inc (SRPT) ?

did-hedge-funds-make-the-right-call-on-sarepta-therapeutics-inc-(srpt)-?

We know that hedge funds generate strong, risk-adjusted returns over the long run, which is why imitating the picks that they are collectively bullish on can be a profitable strategy for retail investors. With billions of dollars in assets, professional investors have to conduct complex analyses, spend many resources and use tools that are not … Read more Did Hedge Funds Make The Right Call On Sarepta Therapeutics Inc (SRPT) ?